Acremonidins A-E (1-5) were produced by fermentation of Acremonium sp., LL-Cyan 416, in heterogeneous phases. The structures of these compounds, containing a bridging keto group, were determined by spectroscopic analysis. Acremonidins A and B showed moderate activity against Gram-positive bacteria, including the methicillin-resistant staphylococci and vancomycin-resistant enterococci. Selective acylations of acremonidin B afforded ester derivatives 6-9 that exhibited improved antibacterial activity. Selective acylations on the acremonidin B afforded some ester derivatives 6-9 that exhibited improved antibacterial potency. In this paper, the production, isolation, structural determination, and derivatization of these new antibiotics are reported.
that affect the physiological state of microorganisms, and thereby modulate biosynthetic pathways with the capacity to produce useful compounds.1,2) Previously, we reported the production of two antimicrobial fungal metabolites, pyrrocidines A and B, by fermentation in heterogeneous phases.3) In the course of our continuing search for novel antibiotics to combat drug-resistance in antibacterial chemotherapy,4,5) we further investigated this fermentation approach. Among the several fungal cultures studied, an Acremonium sp., strain LL-Cyan 416, was found to produce much enhanced antibacterial activity when fermented with this method. Five new compounds, designated acremonidins A-E (1-5), were purified from the methanol extract. Acremonidins A and B showed moderate activity against Gram-positive bacteria, including the methicillinresistant staphylococci and vancomycin-resistant enterococci. The structures of these compounds, featuring a keto bridge, were determined by spectroscopic analysis.
Selective acylations on the acremonidin B afforded some ester derivatives 6-9 that exhibited improved antibacterial potency. In this paper, the production, isolation, structural determination, and derivatization of these new antibiotics are reported.
Results and Discussions

Production and Structures
Culture LL-Cyan 416 was inoculated on moist milk-filter paper placed on the surface of a solid medium containing agar, malt extract, peptone, and yeast extract and incubated incubation, the milk-filter paper bearing prolific mycelial growth was removed from the surface of the agar, lyophilized, and then extracted with methanol. The extract was chromatographed by reversed phase HPLC on C18 columns using a gradient acidic acetonitrile in water to afford acremonidins A-E (1-5).
The molecular formula of acremonidin A (1) was determined to be C33H26O12 by high resolution Fourier transform ion cyclotron resonance (FTICR) mass spectrometry. The 13C NMR spectrum displayed 33 signals, which were assigned to 2 -CH3, 1 OCH3, 1 OCH<, 1 >CH2, 1>CH-, 7 -CH=, and 12 quaternary sp2 carbons using the DEPT experiment. The 1H NMR spectrum and 6.13), a 1,2,3,4-tetrasubstituted phenyl group (6.94 and 6.82, F ring) and a 1,2,3,5-tetrasubstituted phenyl group (6.92 and 6.86, A ring). In addition, 6 D2O exchangeable peaks were observed, which were assigned to phenolic OH signals. The 1H and 13C NMR spectral data, together with the correlations in an HMBC spectrum of 1 are listed in Table 1 .
Detailed analysis of 2-D NMR data, in particular, the multiple bond correlations in the HMBC spectrum, revealed the structure of 1. The strong HMBC correlations from the methine proton H-2 to C-1', C-2', and C-3', from the methylene protons CH2-15' to C-2', C-3', and C-4', and from the aromatic proton H-4' to C-2' and C-6', along with those from the phenolic 1'-OH and 5'-OH to the aromatic carbon signals (Table 1) The relative stereochemistry of C-2, C-5, and C-6 was determined on the basis of an NOE study. The observation the ROESY spectrum required that the H-6 and C-15' be synfacial, which resulted in a (2S*,5R*,6S*) relative configuration.
The molecular formula of acremonidin B (2) was C2H2O less than compound 1. The lack of acetyl signals in the 1H and 13C NMR spectral data and the upfield shift of the H-6 signal both indicated that the acetoxy group in 1 was replaced by a hydroxyl in 2. Acremonidin B (2) was obtained quantitatively by hydrolysis of 1 in a solution of 1:1 Et2O/MeOH containing 0.5M HCl at ambient temperature in 16 hours.
The molecular formula of acremonidin C (3), C33H26O13, contained one more oxygen than compound 1. The 13C C-14 at 81.5 could all be attributed to the presence of a 14-The molecular formula of acremonidin E (4) was Acremonidin E (5) was determined by analysis of highresolution FTICRMS and NMR spectral data to have a benzophenone structure, which was contained in 4. The dehydrated form of compound 5, the 1-carboxylic acid, 2,8-dihydroxy-6-methyl-xanthone methyl ester, or pinselin, was isolated from the roots of Cassia sp.8) Table 3 . A comparison of the MICs of 1 and 2 revealed the importance of the C-6 acetyl group for retaining antimicrobial potency. In order to investigate the potential of these of antibiotics, a series of ester derivatives 6-9 with an acyl group at 6-OH were synthesized by selective acylations on 2.
Acremonidin B (2) was treated with an anhydride in the to afford an ester as shown in Fig. 2 . The products 6-9, generated by several analogous reactions, were tested against a panel of bacteria. The SAR data (Table 4) implied that the attachment of a longer hydrophobic acyl group at C-6 enhanced antibacterial potency against streptococci and enterococci, but the enhancement quickly reached the maximum with the isobutyrate 7 and pentanoate derivative 8. and 13C NMR data see Table 2 . 
